Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma

NCT00226915 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

637

Enrollment

OTHER

Sponsor class

Conditions

Epithelial Ovarian Cancer
Primary Peritoneal Cancer
Fallopian Tube Cancer

Interventions

DRUG: Paclitaxel+Carboplatin
DRUG: Paclitaxel+Carboplatin

Sponsor

Japanese Gynecologic Oncology Group